Currently, there was only one published study examining the association between B2M and Parkinson's disease, which reported a notably elevated B2M concentration in the CSF of Parkinson's patients, even surpassing that of Alzheimer's disease patients (Zhang et al. 2008). The gene discussed is B2M; the disease is early-onset autosomal dominant Alzheimer disease.